Actos Bladder Cancer Lawsuit | Actos Lawsuit Settlements

Georgia Woman Sues Takeda, Says Actos Use Led to Bladder Cancer

Staff Writer | November 22nd, 2011

In the latest Actos bladder cancer lawsuit, Georgia resident Helen Olah has sued Actos drug maker Takeda Pharmaceuticals for failing to disclose the risks associated with their blockbuster diabetes drug. Olah hired an Actos lawyer, experienced in going after Actos lawsuit settlements, after she developed bladder cancer following several years of Actos ingestion, and seeks in excess of $75,000 in damages.

Filed on November 4, 2011 in the U.S. District Court, Northern District of Illinois, Olah’s Actos bladder cancer lawsuit indicates that she began taking Actos in 2003 for treatment of Type 2 diabetes. In October of 2010, Olah was diagnosed with bladder cancer, and she ceased using the drug in October of 2011. She now joins many other plaintiffs around the country with similar stories, all of whom are seeking Actos lawsuit settlements.

Actos bladder cancer lawsuit alleges willful deception by Takeda

In Olah’s Actos bladder cancer lawsuit complaint, her Actos lawyer alleges that Takeda “concealed and continue to conceal their knowledge of Actos’ unreasonably dangerous risks from [Olah], her physician(s), other consumers, and the medical community.”

Olah’s Actos lawyer further contends in her Actos bladder cancer lawsuit that she would not have used Actos if she had been adequately informed of the risks associated with the drug’s long-term use. As with numerous other injured patients pursuing Actos lawsuit settlements by filing an Actos bladder cancer lawsuit, Olah seeks more than $75,000 in damages for pain and suffering, economic losses, Actos lawyer fees and reimbursement of past, present and future medical expenses.

Bladder cancer risk draws attention of Actos lawyer, U.S. officials

Plaintiffs filing an Actos bladder cancer lawsuit aren’t the only ones discovering a likely link between Actos and bladder cancer. Approved by the FDA in 1999 for the treatment of Type 2 diabetes, Actos has met with significant scrutiny from government officials in recent years, particularly after the increase of patients who have come forward seeking Actos lawsuit settlements.

Plaintiffs who have filed an Actos bladder cancer lawsuit have been validated by the fact that the FDA has issued multiple safety alerts about the drug’s link to bladder cancer. Most recently, in June of 2011, the FDA stated that “use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” The national health agency required that drug warning labels highlight this risk, which has been referenced by many plaintiffs in an Actos bladder cancer lawsuit. In June of 2011, both French and German officials pulled Actos from the shelves due to its link with bladder cancer, a disease that has now become the basis of numerous Actos lawsuit settlements.

But while the drug was being pulled from markets abroad, scrutinized by health officials in the U.S., and targeted by plaintiffs in an Actos bladder cancer lawsuit, Takeda neglected to recall the drug from U.S. shelves, continuing to maintain its safety and effectiveness despite the growing number of patients seeking compensation for Actos side effects, which can also include Actos heart failure, through the means of Actos lawsuit settlements.

As Olah’s Actos lawyer alleges in her Actos bladder cancer lawsuit, “With the knowledge of the true relationship between long-term use of Actos and developing bladder cancer, rather than take steps to pull the drug off the market, [Takeda} promoted Actos as a safe and effective treatment for Type 2 diabetes.”

Plaintiffs filing an Actos bladder cancer lawsuit await Actos lawsuit settlements

Though Actos lawsuit settlements are impossible to predict, the number of plaintiffs filing an Actos bladder cancer lawsuit continues to rise, prompting several cases to be consolidated into multidistrict litigation (MDL). Because of the similar claims made by so many plaintiffs filing an Actos bladder cancer lawsuit – specifically, allegations that patients developed bladder cancer after long-term Actos use – Actos lawsuit settlements could be substantial if an Actos lawyer can prove that Takeda was negligent in disclosing the risks associated with their drug.